Palatin Technologies Inc. (NYSEMKT:PTN)

Palatin Technologies, Inc is a development-stage medical technology company involved in developing and commercializing products and technologies for diagnostic imaging, cancer therapy and ethical drug development These developments are based on its proprietary monoclonal antibody radiolabeling and enabling peptide platform technologies.

Palatin Technologies Inc. (NYSEMKT:PTN)’s Financial Overview

Palatin Technologies Inc. (NYSEMKT:PTN) declined -0.4% yesterday to close its trading session at $0.82. The company has 1 year Price Target of $5.67. Palatin Technologies Inc. has 52-Week high of $0.9 and 52-Week Low of $0.36. The stock touched its 52-Week High on Nov 30, 2016 and 52-Week Low on Mar 17, 2016. The stock traded with the volume of 7.61 Million shares yesterday. The firm shows the market capitalization of $88.23 Million.

Palatin Technologies Inc. (NYSEMKT:PTN) reported its last quarterly earnings on Jun 16 where the firm reported its Actual EPS of $-0.08/share against the analyst consensus estimate of $-0.06/share. The difference between the actual and expected EPS is $-0.02 a share with a surprise factor of -33.3%.

The firm is trading with SMA20 of 46.39 Percent, SMA50 of 44.17 Percent and SMA200 of 53.89 percent. Palatin Technologies Inc. has P/S value of 0 while its P/B value stands at 0. Similarly, the company has Return on Assets of -253.6 percent, Return on Equity of 572.6 percent and Return on Investment of 0 Percent. The company shows Gross Margin and Operating Margin of 0 percent and 0 percent respectively.

Many brokerage firms are involved in issuing their ratings on Palatin Technologies Inc. (NYSEMKT:PTN). On 23-May-12 Noble Financial Initiated Palatin Technologies Inc. Stock  to Buy. Another firm also rated the stock on 23-Jan-07 where Next Generation Initiated the stock to Buy.

The Stock currently has Analyst’ mean Recommendation of 1.7 where the scale is from 1 to 5, 1 means Strong Buy and 5 means Sell.

The 3 analysts offering 12-month price forecasts for Palatin Technologies Inc have a median target of 6.00, with a high estimate of 7.00 and a low estimate of 4.00. The median estimate represents a +634.66% increase from the last price of 0.82.

Our vendor, Zacks Investment Research, hasn’t provided us with the upcoming earnings report date.

Ambev S.A. (NYSE:ABEV)

Companhia de Bebidas das Americas (AmBev), based in São Paulo, is engaged in producing, distributing and selling beer, carbonated soft drinks and other non-alcoholic and non-carbonated products in many countries across the Americas. It maintains an agreement with PepsiCo International, Inc. to bottle, sell and distribute Pepsi products in Brazil and in other Latin American countries, including Lipton Ice Tea, Gatorade, H2OH!, Propel and Frutzzz. AmBev conducts its operations through three business units: Latin America North, Latin America South and Canada. Latin America North includes its operations in Brazil, where it operates two divisions: beer sales and carbonated soft drinks and non-alcoholic non-carbonated sales; and its operations in its Hispanic Latin America Operations, excluding Latin America South, operations. Latin America South includes its Quinsa operations in the countries of Argentina, Bolivia, Paraguay, Uruguay and Chile. Canada, represented by Labatt, includes domestic sales in Canada.

Ambev S.A. (NYSE:ABEV)’s Financial Outlook

The 15 analysts offering 12-month price forecasts for Ambev have a median target of 6.34, with a high estimate of 7.10 and a low estimate of 5.40. The median estimate represents a +27.03% increase from the last price of 4.99.

Our vendor, Zacks Investment Research, hasn’t provided us with the upcoming earnings report date.

According to Zacks Investment Research, Ambev S.A. has a Consensus Recommendation of 2.5. (The Scale is from 1-5 where 1 means Strong Buy and 5 means Strong Sell).

The Stock gained 0% and closed its last trading session at $4.99. The company has the market capitalization of $78.34 Billion. The stock has 52-week high of $6.34 and 52-Week low of $3.86. The firm touched its 52-Week high on Oct 24, 2016 and 52-Week low on Jan 21, 2016. The company has volume of 30.01 Million shares. The company has a total of 15.7 Billion shares outstanding.

Ambev S.A. (NYSE:ABEV) in the last quarter reported its actual EPS of $0.05/share where the analyst estimated EPS was $0.06/share. The difference between the actual and Estimated EPS is $-0.01. This shows a surprise factor of -16.7 percent.

The company has YTD performance of 11.88 percent. Beta for Ambev S.A. stands at 0 while its ATR (average true range) is 0.17. The company has Weekly Volatility of 3.06%% and Monthly Volatility of 2.77%%.

Ambev S.A. has distance from 20-day Simple Moving Average (SMA20) of -5.12%, Distance from 50-Day Simple Moving Average of -13.32 percent and Distance from 200-Day Simple Moving Average of -10.14%.

The Company currently has ROA (Return on Assets) of 0 percent, Return on Equity (ROE) of 0 Percent and Return on Investment (ROI) of 0% with Gross margin of 0 percent and Operating & Profit margin of 0% and 0% respectively.